- Home
- J vs DGX Comparison
J vs DGX Comparison
Compare J & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- J
- DGX
- Stock Information
- Founded
- J 1947
- DGX 1967
- Country
- J United States
- DGX United States
- Employees
- J N/A
- DGX N/A
- Industry
- J Military/Government/Technical
- DGX Medical Specialities
- Sector
- J Industrials
- DGX Health Care
- Exchange
- J Nasdaq
- DGX Nasdaq
- Market Cap
- J 16.4B
- DGX 17.5B
- IPO Year
- J N/A
- DGX 1996
- Fundamental
- Price
- J $128.99
- DGX $172.26
- Analyst Decision
- J Buy
- DGX Buy
- Analyst Count
- J 11
- DGX 13
- Target Price
- J $155.89
- DGX $177.69
- AVG Volume (30 Days)
- J 885.0K
- DGX 1.2M
- Earning Date
- J 02-04-2025
- DGX 01-30-2025
- Dividend Yield
- J 0.89%
- DGX 1.86%
- EPS Growth
- J N/A
- DGX 2.67
- EPS
- J 4.86
- DGX 7.69
- Revenue
- J $11,623,670,000.00
- DGX $9,872,000,000.00
- Revenue This Year
- J N/A
- DGX $10.18
- Revenue Next Year
- J $10.82
- DGX $3.82
- P/E Ratio
- J $26.41
- DGX $22.37
- Revenue Growth
- J 17.85
- DGX 6.70
- 52 Week Low
- J $111.23
- DGX $123.66
- 52 Week High
- J $150.54
- DGX $172.91
- Technical
- Relative Strength Index (RSI)
- J 34.52
- DGX 70.79
- Support Level
- J $128.31
- DGX $166.15
- Resistance Level
- J $131.24
- DGX $172.64
- Average True Range (ATR)
- J 3.34
- DGX 3.27
- MACD
- J -0.56
- DGX 0.74
- Stochastic Oscillator
- J 4.08
- DGX 94.96
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.